PUBLISHER: TechNavio | PRODUCT CODE: 2056231
PUBLISHER: TechNavio | PRODUCT CODE: 2056231
Global Cell And Gene Therapy Supply Chain Software Market 2026-2030
The global cell and gene therapy supply chain software market is forecasted to grow by USD 292 mn during 2025-2030, accelerating at a CAGR of 15.2% during the forecast period. The report on the global cell and gene therapy supply chain software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by accelerated clinical development and commercialization, mandatory chain of identity and custody requirements, rise of personalized autologous treatment modalities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 14.5% |
| CAGR | 15.2% |
| Incremental Value | $292 mn |
Technavio's global cell and gene therapy supply chain software market is segmented as below:
By Type
- Enterprise manufacturing system
- Laboratory information management system
- Cell orchestration platform
- Inventory management system
- Others
By End-User
- Pharmaceutical companies
- Contract manufacturers
- Hospitals
- Research institutes
By Deployment
- Clinical scale
- Commercial scale
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Switzerland
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the integration of artificial intelligence for predictive optimization as one of the prime reasons driving the global cell and gene therapy supply chain software market growth during the next few years. Also, adoption of cloud-native orchestration architectures and implementation of distributed ledger technology for data security will lead to sizable demand in the market.
The report on the global cell and gene therapy supply chain software market covers the following areas:
- Global cell and gene therapy supply chain software market sizing
- Global cell and gene therapy supply chain software market forecast
- Global cell and gene therapy supply chain software market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global cell and gene therapy supply chain software market vendors that include Appian Corp., Benchling Inc., Cencora Inc., Cryoport Systems, LLC, Cytiva, Emerson Electric Co., Honeywell International Inc., Korber Pharma GmbH, LabVantage Solutions Inc., Lonza Group Ltd., MasterControl Solutions Inc., McKesson Corp., Oracle Corp., Salesforce Inc., SAP SE, Siemens AG, Thermo Fisher Scientific Inc., TraceLink Inc., TrakCel, Veeva Systems Inc.. Also, the global cell and gene therapy supply chain software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Deployment
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Cell And Gene Therapy Supply Chain Software Market 2020 - 2024
- Historic Market Size - Data Table on Global Cell And Gene Therapy Supply Chain Software Market 2020 - 2024 ($ million)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.3 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.4 Deployment segment analysis 2020 - 2024
- Historic Market Size - Deployment Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global cell and gene therapy supply chain software market
- 6.2 Impact of geopolitical conflicts on global cell and gene therapy supply chain software market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Enterprise manufacturing system - Market size and forecast 2025-2030
- 8.4 Laboratory information management system - Market size and forecast 2025-2030
- 8.5 Cell orchestration platform - Market size and forecast 2025-2030
- 8.6 Inventory management system - Market size and forecast 2025-2030
- 8.7 Others - Market size and forecast 2025-2030
- 8.8 Market opportunity by Type
- Market opportunity by Type ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- 9.2 Comparison by End-user
- 9.3 Pharmaceutical companies - Market size and forecast 2025-2030
- 9.4 Contract manufacturers - Market size and forecast 2025-2030
- 9.5 Hospitals - Market size and forecast 2025-2030
- 9.6 Research institutes - Market size and forecast 2025-2030
- 9.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
10 Market Segmentation by Deployment
- 10.1 Market segments
- 10.2 Comparison by Deployment
- 10.3 Clinical scale - Market size and forecast 2025-2030
- 10.4 Commercial scale - Market size and forecast 2025-2030
- 10.5 Market opportunity by Deployment
- Market opportunity by Deployment ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.4.7 Switzerland - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 South Korea - Market size and forecast 2025-2030
- 12.5.4 India - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Vietnam - Market size and forecast 2025-2030
- 12.5.7 Singapore - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Australia - Market size and forecast 2025-2030
- 12.6.2 Brazil - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 South Africa - Market size and forecast 2025-2030
- 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.6 Turkey - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Accelerated clinical development and commercialization
- Mandatory chain of identity and custody requirements
- Rise of personalized autologous treatment modalities
- 13.2 Market challenges
- Regulatory heterogeneity and global compliance burdens
- Interoperability barriers and system fragmentation
- High initial capital requirements and expertise deficits
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Integration of artificial intelligence for predictive optimization
- Adoption of cloud-native orchestration architectures
- Implementation of distributed ledger technology for data security
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Appian Corp.
- Appian Corp. - Overview
- Appian Corp. - Business segments
- Appian Corp. - Key offerings
- Appian Corp. - Segment focus
- SWOT
- 15.5 Cencora Inc.
- Cencora Inc. - Overview
- Cencora Inc. - Business segments
- Cencora Inc. - Key offerings
- Cencora Inc. - Segment focus
- SWOT
- 15.6 Cryoport Systems, LLC
- Cryoport Systems, LLC - Overview
- Cryoport Systems, LLC - Product / Service
- Cryoport Systems, LLC - Key offerings
- SWOT
- 15.7 Cytiva
- Cytiva - Overview
- Cytiva - Product / Service
- Cytiva - Key offerings
- SWOT
- 15.8 Emerson Electric Co.
- Emerson Electric Co. - Overview
- Emerson Electric Co. - Business segments
- Emerson Electric Co. - Key news
- Emerson Electric Co. - Key offerings
- Emerson Electric Co. - Segment focus
- SWOT
- 15.9 Honeywell International Inc.
- Honeywell International Inc. - Overview
- Honeywell International Inc. - Business segments
- Honeywell International Inc. - Key news
- Honeywell International Inc. - Key offerings
- Honeywell International Inc. - Segment focus
- SWOT
- 15.10 McKesson Corp.
- McKesson Corp. - Overview
- McKesson Corp. - Business segments
- McKesson Corp. - Key offerings
- McKesson Corp. - Segment focus
- SWOT
- 15.11 Oracle Corp.
- Oracle Corp. - Overview
- Oracle Corp. - Business segments
- Oracle Corp. - Key news
- Oracle Corp. - Key offerings
- Oracle Corp. - Segment focus
- SWOT
- 15.12 Salesforce Inc.
- Salesforce Inc. - Overview
- Salesforce Inc. - Business segments
- Salesforce Inc. - Key news
- Salesforce Inc. - Key offerings
- Salesforce Inc. - Segment focus
- SWOT
- 15.13 SAP SE
- SAP SE - Overview
- SAP SE - Business segments
- SAP SE - Key news
- SAP SE - Key offerings
- SAP SE - Segment focus
- SWOT
- 15.14 Siemens AG
- Siemens AG - Overview
- Siemens AG - Business segments
- Siemens AG - Key news
- Siemens AG - Key offerings
- Siemens AG - Segment focus
- SWOT
- 15.15 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.16 TraceLink Inc.
- TraceLink Inc. - Overview
- TraceLink Inc. - Product / Service
- TraceLink Inc. - Key offerings
- SWOT
- 15.17 TrakCel
- TrakCel - Overview
- TrakCel - Product / Service
- TrakCel - Key offerings
- SWOT
- 15.18 Veeva Systems Inc.
- Veeva Systems Inc. - Overview
- Veeva Systems Inc. - Business segments
- Veeva Systems Inc. - Key offerings
- Veeva Systems Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
